NO901303D0 - Nye benzotiopyranylaminer. - Google Patents

Nye benzotiopyranylaminer.

Info

Publication number
NO901303D0
NO901303D0 NO901303A NO901303A NO901303D0 NO 901303 D0 NO901303 D0 NO 901303D0 NO 901303 A NO901303 A NO 901303A NO 901303 A NO901303 A NO 901303A NO 901303 D0 NO901303 D0 NO 901303D0
Authority
NO
Norway
Prior art keywords
benzotiopyrany
lamines
new
und
dieser verbindungen
Prior art date
Application number
NO901303A
Other languages
English (en)
Other versions
NO901303L (no
NO174669C (no
NO174669B (no
Inventor
Alan J Hutchison
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO901303D0 publication Critical patent/NO901303D0/no
Publication of NO901303L publication Critical patent/NO901303L/no
Publication of NO174669B publication Critical patent/NO174669B/no
Publication of NO174669C publication Critical patent/NO174669C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Tea And Coffee (AREA)
  • Indole Compounds (AREA)
NO901303A 1989-03-22 1990-03-21 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer NO174669C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32694989A 1989-03-22 1989-03-22

Publications (4)

Publication Number Publication Date
NO901303D0 true NO901303D0 (no) 1990-03-21
NO901303L NO901303L (no) 1990-09-24
NO174669B NO174669B (no) 1994-03-07
NO174669C NO174669C (no) 1994-06-15

Family

ID=23274473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901303A NO174669C (no) 1989-03-22 1990-03-21 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer

Country Status (22)

Country Link
US (1) US5071858A (no)
EP (1) EP0389425B1 (no)
JP (1) JPH06102657B2 (no)
KR (1) KR900014357A (no)
AT (1) ATE121740T1 (no)
AU (1) AU632318B2 (no)
CA (1) CA2012569A1 (no)
DD (1) DD292913A5 (no)
DE (1) DE69018864D1 (no)
DK (1) DK0389425T3 (no)
ES (1) ES2071074T3 (no)
FI (1) FI94863C (no)
GR (1) GR3015938T3 (no)
HU (1) HU206205B (no)
IE (1) IE67871B1 (no)
IL (2) IL93814A (no)
MX (1) MX19953A (no)
NO (1) NO174669C (no)
NZ (1) NZ233002A (no)
PT (1) PT93515B (no)
TW (1) TW204347B (no)
ZA (1) ZA902168B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE136461T1 (de) * 1990-08-13 1996-04-15 Searle & Co Verwendung von heterozyklischen aminoalkoholverbindungen zur herstellung eines medikaments für die behandlung von erkrankungen des zns
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5428307A (en) * 1993-10-20 1995-06-27 Silicon Systems, Inc. Closed-loop peak detector topology
JPH0967367A (ja) * 1995-06-23 1997-03-11 Suntory Ltd チオピラン誘導体
FR2739855B1 (fr) * 1995-10-13 1997-11-14 Adir Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050148018A1 (en) * 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077733B1 (no) * 1970-02-10 1973-03-16 Roussel Uclaf
GB1407552A (en) * 1973-04-02 1975-09-24 Science Union & Cie Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4468404A (en) * 1980-12-12 1984-08-28 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
FI79535C (fi) * 1982-05-06 1990-01-10 Erba Farmitalia Foerfarande foer framstaellning av dihydrobensopyrans och dihydrobensotiopyrans substituerade iminoderivat.
GB8515389D0 (en) * 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
ATE65084T1 (de) * 1986-06-26 1991-07-15 Ciba Geigy Ag Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen.
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
ES2059828T3 (es) * 1988-01-15 1994-11-16 Abbott Lab Un procedimiento para la preparacion de un compuesto.
EP0471515B1 (en) * 1990-08-15 1997-03-05 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes

Also Published As

Publication number Publication date
NO901303L (no) 1990-09-24
EP0389425B1 (de) 1995-04-26
MX19953A (es) 1994-01-31
HUT53632A (en) 1990-11-28
ES2071074T3 (es) 1995-06-16
KR900014357A (ko) 1990-10-23
IL93814A (en) 1995-07-31
TW204347B (no) 1993-04-21
NO174669C (no) 1994-06-15
DD292913A5 (de) 1991-08-14
HU901636D0 (en) 1990-11-28
ZA902168B (en) 1990-11-28
JPH06102657B2 (ja) 1994-12-14
CA2012569A1 (en) 1990-09-22
NZ233002A (en) 1992-07-28
FI94863B (fi) 1995-07-31
US5071858A (en) 1991-12-10
AU5208690A (en) 1990-11-08
NO174669B (no) 1994-03-07
DE69018864D1 (de) 1995-06-01
FI94863C (fi) 1995-11-10
HU206205B (en) 1992-09-28
PT93515B (pt) 1996-08-30
IE901036L (en) 1990-09-22
DK0389425T3 (da) 1995-05-22
ATE121740T1 (de) 1995-05-15
GR3015938T3 (en) 1995-07-31
IL93814A0 (en) 1990-12-23
FI901371A0 (fi) 1990-03-19
EP0389425A1 (de) 1990-09-26
AU632318B2 (en) 1992-12-24
PT93515A (pt) 1990-11-07
IE67871B1 (en) 1996-05-01
JPH037280A (ja) 1991-01-14

Similar Documents

Publication Publication Date Title
ATE79264T1 (de) Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
NL300140I1 (nl) Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69115989D1 (de) Verwendung von 1-(2-Naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur Herstellung eines Medikaments zur Behandlung von zerebralen und neuronalen Krankheiten
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE59302501D1 (de) Substituierte Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE69013880D1 (de) Verfahren und Vorrichtung zur Behandlung von Absorptionssuspensionen, die Flugasche beinhalten.
DE69023410D1 (de) Verfahren und Vorrichtung zur Herstellung von Pellets.
ATE6032T1 (de) Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
NO901303L (no) Nye benzotiopyranylaminer.
DE59208837D1 (de) Strahlungsempfindliches Gemisch, enthaltend säurelabile Gruppierungen und Verfahren zur Herstellung von Reliefmustern und Reliefbildern
DE59106745D1 (de) Strahlungsempfindliches Gemisch, hiermit hergestelltes strahlungsempfindliches Aufzeichnungsmaterial und Verfahren zur Herstellung von Reliefaufzeichnungen.
ATE135220T1 (de) Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose
DE69012808D1 (de) Vorrichtung zur behandlung von lebenden fischen und fischbrut und deren verwendung.
DE59003390D1 (de) Verfahren zur Herstellung von Butandiol-1,4 und Tetrahydrofuran.
ATE6643T1 (de) Neue 3,4-diaza-bicyclo(4.1.0)hepten-(2)-one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel.
DE3674213D1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
ATE113598T1 (de) Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATA498381A (de) Verfahren zur herstellung von neuen 1,7,7-trimethylbicyclo(2.2.1)heptan-2-onoximaeth rn, diese verbindungen enthaltende pflanzenwachstumsregulierende mittel und verwendung der mittel
DE69000960D1 (de) Zusammensetzung zur behandlung von pigmentierung.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
PT76582A (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
PT88572A (pt) Verfahren zur herstellung von neuen 7-diphenylmethyenbicycloheptanen und 7-diphenylmethylenbicycloheptenen und von pharmaezeutischen zusammensetzungen die diese enthalten
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.